Biochemical relapse-free survival
WebApr 19, 2024 · The pooled reported rate of biochemical recurrence-free survival (BRFS defined as PSA < 0.2 or WebApr 19, 2024 · Biochemical recurrence-free survival The pooled reported rate of biochemical recurrence-free survival (BRFS defined as PSA < 0.2 or
Biochemical relapse-free survival
Did you know?
Webde la Taille et al [28] recently reported a biochemical failure-free survival rate of 66% at 12 months in a series of 43 salvage patients, with low complication rates. In their … WebJul 15, 2008 · Biochemical relapse-free survival. Figure 1 shows biochemical relapse-free survival outcomes according to the National Comprehensive Cancer Network recurrence risk groupings. Overall 7-year actuarial PSA relapse-free survival outcome for low-risk patients was 90% (95% confidence interval [CI], 88–92). Seven-year PSA …
WebOct 19, 2015 · Biochemical progression-free survival in localized prostate cancer patients treated with definitive external beam radiotherapy Electron Physician. 2015 Oct 19;7 (6):1330-5. doi: 10.14661/1330. eCollection 2015 Oct. Authors Afshin Rakhsha 1 , Amir Shahram Yousefi Kashi 1 , Bahram Mofid 2 , Mohammad Houshyari 1 Affiliations WebSep 10, 2024 · The 1 and 2-year BCR-free survival were 88.6 and 85.1% for the favorable group, 73.3 and 53.1% for the intermediate group, and 32.7 and 16.4% for the unfavorable group, respectively. From a clinical standpoint, this information may help urologists and patients during a shared decision making process.
WebJun 23, 2024 · Kaplan-Meier curve of biochemical recurrence-free survival after open retropubic radical prostatectomy (RRP) and robot-assisted laparoscopic radical prostatectomy (RALP) in the entire study ... Webi. introduction..... 1 ii. background .....
WebAt a median follow-up time of 21 months (range, 6–32 months), the median biochemical progression-free survival was 19 months (range, 4 to 23 months) in the radiotherapy group, as compared with 16.5 months (range, 4 to 28 months) in the surgery group.
WebBRFS, biochemical recurrence-free survival (Kaplan-Meier curve analysis). We found that the biochemical recurrence-free survivals differed between the group of patients who reached a PSA nadir less than 0.1 ng/ml (undetectable) versus patients who did not reached a undetectable serum PSA (73% vs. 30%, logrank = 7.11, P = 0.0076). fmea introductionWebObjective: To compare biochemical recurrence (BCR)-free survival and predictors of BCR in intermediate-risk (IR) and high-risk (HR) patients undergoing robotic-assisted … fmea inputs and outputsWebMar 11, 2009 · The authors found that it took an average of eight years for the cancer to metastasize to the bones, and the men survived another five years after that — for a total of 13 years, on average, after biochemical recurrence. greensborough shopping centre opening hoursWebNov 22, 2024 · Biochemical progression free survival (BPFS), clinical progression free survival (CPFS), and cancer-specific survival (CSS) rates were estimated using … greensborough shopping centreWebNCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. fmea iso 14971WebApr 12, 2024 · Biochemical recurrence 3 years posttherapy with PSA = 0.37. (A) Four hours image and (B) 24 h image show a 3 mm right external iliac metastatic lymph node (SUV max = 8). (C) The node (arrow) on the axial CT scan. ... linked to other outcome measures such as biochemical recurrence-free survival. 22, ... greensborough shopping plazaWebAim: Biochemical relapse-free survival (bRFS) rate is determined by a cohort of Mexican patients (n = 595) with prostate cancer who received treatment with external … greensborough shopping